Princeton

To optimize patient safety and efficacy of therapy, we personalize radiopharmaceutical treatment using dosimetry based on qSPECT/CT imaging. Over time, we measure the biological clearance of the administered radiopharmaceuticals dynamically to obtain precise measurements of the doses delivered. This helps in accurately characterizing dose delivery to healthy organs at risk, such as the liver and kidneys, dose to tumors, and appropriate clearance from the body over time to ensure the safest and most personalized treatment possible.